Search Query :
9JJ7
The crystal structure of sars-cov-2 nsp5 in complex with eif4g2 Deposition Author(s): Jin, Z. , Wang, Y. , Yan, X. , Zhang, J.
Date: 2024-09-13 Method: X-RAY DIFFRACTION Resolution: 1.8 Å Organism(s): Severe Acute Respiratory Syndrome Coronavirus 2 , Synthetic Construct Sequences Data: 9JJ7_A , 9JJ7_C
9JRC
Crystal structure of sars-cov-2 receptor-binding domain complexed with squirrel ace2 Deposition Author(s): Lan, J. , Nan, X.
Date: 2024-09-29 Method: X-RAY DIFFRACTION Resolution: 3.16 Å Organism(s): Petaurus Norfolcensis , Severe Acute Respiratory Syndrome Coronavirus 2 Sequences Data: 9JRC_B , 9JRC_E
9JTE
Crystal structure of sars-cov-2 receptor binding domain complexed with fox ace2 Deposition Author(s): Jun, L. , Xiaoyan, N.
Date: 2024-10-04 Method: X-RAY DIFFRACTION Resolution: 3.66 Å Organism(s): Severe Acute Respiratory Syndrome Coronavirus 2 , Vulpes Vulpes Sequences Data: 9JTE_A , 9JTE_B , 9JTE_E , 9JTE_C
9K6J
Crystal structure of sars-cov-2 wt rbd bound with p5-1c8 fab Deposition Author(s): Lv, N.N. , Yang, R.Y.
Date: 2024-10-22 Method: X-RAY DIFFRACTION Resolution: 2.39 Å Organism(s): Homo Sapiens , Severe Acute Respiratory Syndrome Coronavirus 2 Sequences Data: 9K6J_C , 9K6J_A , 9K6J_B
9K6Y
Cryo-em structure of sars-cov-2 prototype spike protein in complex with h4 fab (local refinement) Deposition Author(s): Gao, G.F. , Li, L.J. , Wu, Y. , Zhang, G.
Date: 2024-10-22 Method: ELECTRON MICROSCOPY Resolution: 2.67 Å Organism(s): Homo Sapiens , Severe Acute Respiratory Syndrome Coronavirus 2 Sequences Data: 9K6Y_L , 9K6Y_H , 9K6Y_R
9KGJ
Discovery of an orally bioavailable reversible covalent sars-cov-2 mpro inhibitor with pan-coronavirus activity Deposition Author(s): Baburajendran, N.
Date: 2024-11-08 Method: X-RAY DIFFRACTION Resolution: 1.37 Å Organism(s): Severe Acute Respiratory Syndrome Coronavirus 2 , Synthetic Construct Sequences Data: 9KGJ_A , 9KGJ_B , 9KGJ_C , 9KGJ_D
9KGN
Discovery of an orally bioavailable reversible covalent sars-cov-2 mpro inhibitor with pan-coronavirus activity Deposition Author(s): Baburajendran, N.
Date: 2024-11-08 Method: X-RAY DIFFRACTION Resolution: 1.89 Å Organism(s): Severe Acute Respiratory Syndrome Coronavirus 2 , Synthetic Construct Sequences Data: 9KGN_B , 9KGN_A , 9KGN_C , 9KGN_D
9KGQ
Discovery of an orally bioavailable reversible covalent sars-cov-2 mpro inhibitor with pan-coronavirus activity Deposition Author(s): Baburajendran, N.
Date: 2024-11-08 Method: X-RAY DIFFRACTION Resolution: 1.5 Å Organism(s): Severe Acute Respiratory Syndrome Coronavirus 2 , Synthetic Construct Sequences Data: 9KGQ_B , 9KGQ_A , 9KGQ_C , 9KGQ_D
9KGR
Discovery of an orally bioavailable reversible covalent sars-cov-2 mpro inhibitor with pan-coronavirus activity Deposition Author(s): Baburajendran, N.
Date: 2024-11-08 Method: X-RAY DIFFRACTION Resolution: 1.47 Å Organism(s): Severe Acute Respiratory Syndrome Coronavirus 2 , Synthetic Construct Sequences Data: 9KGR_A , 9KGR_B , 9KGR_C , 9KGR_D
9KGS
Discovery of an orally bioavailable reversible covalent sars-cov-2 mpro inhibitor with pan-coronavirus activity Deposition Author(s): Baburajendran, N.
Date: 2024-11-09 Method: X-RAY DIFFRACTION Resolution: 2.2 Å Organism(s): Severe Acute Respiratory Syndrome Coronavirus 2 , Synthetic Construct Sequences Data: 9KGS_B , 9KGS_A , 9KGS_C , 9KGS_D